NDA 21-551/S-006 Page 9 17.4 FDA-Approved Patient Labeling • HalfLytely and Bisacodyl Tablets Bowel Prep Kit produces a watery stool which cleanses ... more>>
NDA 20-441/S-020 Page 21 33021-00 Patient’s Instructions For Use For Oral Inhalation Only. Please read this leaflet carefully before you start to ... more>>
NDA 21-574/S-006 Page 24 PATIENT INFORMATION ABOUT FORTAMET® (metformin hydrochloride) ExtendedRelease Tablets Rx only Q1. Why do I need to take ... more>>
NDA 20-505/S-002 NDA 20-844/S-010 Approved Labeling Text dated 08/28/01 Page 6 WARNINGS Acute myopia and secondary angle closure glaucoma A syndrome c ... more>>
NDA 20-152 AttachmentRx only SERZONE® (nefazodone hydrochloride) Tablets Before prescribing SERZONE, the physician should be thoroughly familiar wi ... more>>
NDA 21-756/S-006 NDA 21-756/S-007 Page 3 MACUGEN® (pegaptanib sodium injection) DESCRIPTION MACUGEN® (pegaptanib sodium injection) is a sterile, aque ... more>>
NDA 16-733/S-049 Page 3 DRAFT PACKAGE INSERT Y36-002-475 Package Insert PIC™ (Plastic Irrigation Container) ________________________________________ ... more>>
Memorandum to File To: NDA 21-210 file From: S. Markofsky (Acting Team Leader) Subject: Storage Statement for Jerome Sevens Pharmaceutical's ... more>>
NDA 21-210 Jerome Stevens Pharmaceuticals, Inc. Attention: Mr. Ronald J. Steinlauf Vice President Sixty DaVinci Drive Bohemia, NY 11716 Dear Mr. ... more>>
sNDA 20-726 FDA MEDICAL AND STATISTICAL ODAC REPORT Drug Name: Femara® Letrozole tablets Applicant: Novartis Date Submitted: July 11, 2000 Date Receiv ... more>>
Meeting Date:January9. 1997 MD: micOna2oic nitrateointmenr Time: 1000 Location:N225 Sponsor:JohnsonandJohnson : Prc-NDA Meeting Chair: ... more>>